ghk-cu subcutaneous dosing FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR GHK-Cu Dosage: Clinical Guidance for

Avoid administration during or immediately after intense exercise

Berthoud, H

Mutations in these genes are linked to the regulation of amyloid-beta processing, a crucial component of AD pathogenesis

Rule 3 Documentation Must Name the Type, Cause, and Lab Evidence

What were building Neurophorol to enable (research-stage endpoints): receptor/pathway profiling + SAR learning neuroimmune and inflammation readouts oxidative stress / resilience markers reproducible preclinical validation workflows Were opening collaboration discussions with teams who can help validate and translate this platform responsibly: (Universities, Biotech companies, Tribal communities, and Investors) CB1/CB2 functional assays + signaling bias analytical chemistry (LCMS/NMR) + stability profiling neuroimmune models (microglia), biomarkers, preclinical design ADME/PK and translational study frameworks If you work in this space, comment NEUROPHOROL or DM your capability stack